Literature DB >> 23515276

Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure.

Sharlene M Day1, Andras Divald, Ping Wang, Frank Davis, Sarah Bartolone, Richard Jones, Saul R Powell.   

Abstract

BACKGROUND: This study examined the hypothesis that 26S proteasome dysfunction in human end-stage heart failure is associated with decreased docking of the 19S regulatory particle to the 20S proteasome. Previous studies have demonstrated that 26S proteasome activity is diminished in human end-stage heart failure associated with oxidation of the 19S regulatory particle Rpt5 subunit. Docking of the 19S regulatory particle to the 20S proteasome requires functional Rpt subunit ATPase activity and phosphorylation of the α-type subunits. METHODS AND
RESULTS: An enriched proteasome fraction was prepared from 7 human nonfailing and 10 failing heart explants. Native gel electrophoresis assessed docking of 19S to 20S proteasome revealing 3 proteasome populations (20S, 26S, and 30S proteasomes). In failing hearts, 30S proteasomes were significantly lower (P=0.048) by 37% suggesting diminished docking. Mass spectrometry-based phosphopeptide analysis demonstrated that the relative ratio of phosphorylated:non phosphorylated α7 subunit (serine250) of the 20S proteasome was significantly less (P=0.011) by almost 80% in failing hearts. Rpt ATPase activity was determined in the enriched fraction and after immunoprecipitation with an Rpt6 antibody. ATPase activity (ρmol PO4/μg protein per hour) of the total fraction was lowered from 291±97 to 194±27 and in the immunoprecipitated fraction from 42±12 to 3±2 (P=0.005) in failing hearts.
CONCLUSIONS: These studies suggest that diminished 26S activity in failing human hearts may be related to impaired docking of the 19S to the 20S as a result of decreased Rpt subunit ATPase activity and α7 subunit phosphorylation.

Entities:  

Keywords:  heart failure; human; phosphorylation; ubiquitin proteasome system

Mesh:

Substances:

Year:  2013        PMID: 23515276      PMCID: PMC3864674          DOI: 10.1161/CIRCHEARTFAILURE.112.000119

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  41 in total

1.  Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia.

Authors:  Saul R Powell; Samson Mathews Samuel; Ping Wang; Andras Divald; Mahesh Thirunavukkarasu; Srikanth Koneru; Xuejun Wang; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2008-01-26       Impact factor: 5.000

2.  Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome-ATPase interactions.

Authors:  Yadong Yu; David M Smith; Ho Min Kim; Victor Rodriguez; Alfred L Goldberg; Yifan Cheng
Journal:  EMBO J       Date:  2009-12-17       Impact factor: 11.598

3.  Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases.

Authors:  Julius Rabl; David M Smith; Yadong Yu; Shih-Chung Chang; Alfred L Goldberg; Yifan Cheng
Journal:  Mol Cell       Date:  2008-05-09       Impact factor: 17.970

Review 4.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

5.  Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies.

Authors:  Jaime M Predmore; Ping Wang; Frank Davis; Sarah Bartolone; Margaret V Westfall; David B Dyke; Francis Pagani; Saul R Powell; Sharlene M Day
Journal:  Circulation       Date:  2010-02-16       Impact factor: 29.690

6.  PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts.

Authors:  Mitsutoshi Asai; Osamu Tsukamoto; Tetsuo Minamino; Hiroshi Asanuma; Masashi Fujita; Yoshihiro Asano; Hiroyuki Takahama; Hideyuki Sasaki; Shuichiro Higo; Masanori Asakura; Seiji Takashima; Masatsugu Hori; Masafumi Kitakaze
Journal:  J Mol Cell Cardiol       Date:  2008-11-13       Impact factor: 5.000

Review 7.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Authors:  Huabo Su; Xuejun Wang
Journal:  Cardiovasc Res       Date:  2009-08-20       Impact factor: 10.787

8.  Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II.

Authors:  Stevan N Djakovic; Lindsay A Schwarz; Barbara Barylko; George N DeMartino; Gentry N Patrick
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

9.  Markers of autophagy are downregulated in failing human heart after mechanical unloading.

Authors:  Christos Kassiotis; Kalpana Ballal; Kari Wellnitz; Deborah Vela; Mei Gong; Rebecca Salazar; O Howard Frazier; Heinrich Taegtmeyer
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 10.  Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Roger J Hajjar; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2009-05-27       Impact factor: 5.000

View more
  21 in total

1.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

Review 2.  The COP9 signalosome and cullin-RING ligases in the heart.

Authors:  Xuejun Wang; Douglas S Martin
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

Review 3.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 4.  Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.

Authors:  Oliver Drews; Heinrich Taegtmeyer
Journal:  Antioxid Redox Signal       Date:  2014-10-01       Impact factor: 8.401

Review 5.  Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil.

Authors:  Hanming Zhang; Xuejun Wang
Journal:  Future Cardiol       Date:  2015-03

Review 6.  The ubiquitin proteasome system in human cardiomyopathies and heart failure.

Authors:  Sharlene M Day
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

Review 7.  Proteasomal and lysosomal protein degradation and heart disease.

Authors:  Xuejun Wang; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-11-14       Impact factor: 5.000

Review 8.  Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.

Authors:  Jie Li; John A Johnson; Huabo Su
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 9.  Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis.

Authors:  Willy Roque; Ross Summer; Freddy Romero
Journal:  Connect Tissue Res       Date:  2018-10-22       Impact factor: 3.417

Review 10.  Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond.

Authors:  Ziyou Cui; Sarah B Scruggs; Jennifer E Gilda; Peipei Ping; Aldrin V Gomes
Journal:  J Mol Cell Cardiol       Date:  2013-10-17       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.